Abstract
The risk of nodal involvement in patients with cancer of the nasal cavity and paranasal sinuses has not been well defined. Current decision-making on whether to cover specific nodal regions is based on interpretation of single-institution retrospective analyses.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have